Multicenter, Single-arm, Phase IV Study to Evaluate the Efficacy, Safety of Combined Therapy of Aspirin and High Dose 'IVIG-SN' in Pediatric Patients With Kawasaki Disease.

Trial Profile

Multicenter, Single-arm, Phase IV Study to Evaluate the Efficacy, Safety of Combined Therapy of Aspirin and High Dose 'IVIG-SN' in Pediatric Patients With Kawasaki Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2012

At a glance

  • Drugs Aspirin; Immunoglobulin G
  • Indications Coronary artery disease; Embolism and thrombosis; Mucocutaneous lymph node syndrome
  • Focus Therapeutic Use
  • Sponsors Green Cross
  • Most Recent Events

    • 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 06 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top